Matches in Wikidata for { <http://www.wikidata.org/entity/Q37737326> ?p ?o ?g. }
- Q37737326 description "article científic" @default.
- Q37737326 description "article scientifique" @default.
- Q37737326 description "articolo scientifico" @default.
- Q37737326 description "artigo científico" @default.
- Q37737326 description "artículu científicu espublizáu en 2017" @default.
- Q37737326 description "bilimsel makale" @default.
- Q37737326 description "scientific article published on March 2017" @default.
- Q37737326 description "vedecký článok" @default.
- Q37737326 description "vetenskaplig artikel" @default.
- Q37737326 description "videnskabelig artikel" @default.
- Q37737326 description "vědecký článek" @default.
- Q37737326 description "wetenschappelijk artikel" @default.
- Q37737326 description "wissenschaftlicher Artikel" @default.
- Q37737326 description "наукова стаття, опублікована в березні 2017" @default.
- Q37737326 description "научни чланак" @default.
- Q37737326 description "مقالة علمية نشرت في مارس 2017" @default.
- Q37737326 name "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 name "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 name "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 type Item @default.
- Q37737326 label "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 label "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 label "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 prefLabel "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 prefLabel "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 prefLabel "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 P1433 Q37737326-B777701D-FD9B-425E-BCDB-52FC640C0EBA @default.
- Q37737326 P1476 Q37737326-E4ADC5C2-7E54-4C26-BBF1-3437A663DF71 @default.
- Q37737326 P2093 Q37737326-8F6AA53C-2DE4-4890-B0F0-B79B7E4431B3 @default.
- Q37737326 P2093 Q37737326-97D7508D-D6D5-45AB-B7AD-579DAF5112D8 @default.
- Q37737326 P2093 Q37737326-992377FB-CB18-4A6B-96DD-43BE57193643 @default.
- Q37737326 P2860 Q37737326-03655A77-8C17-4F75-AAFB-16B06BBEB5DB @default.
- Q37737326 P2860 Q37737326-08EB624F-5613-4AD1-AB44-F6085B275980 @default.
- Q37737326 P2860 Q37737326-0BAE3301-D7AF-48D5-A797-408B8347AAD3 @default.
- Q37737326 P2860 Q37737326-1533E829-FECB-45A2-81A6-D4D1551866F7 @default.
- Q37737326 P2860 Q37737326-16DEBCAD-CF13-4A6B-9298-861F482F6953 @default.
- Q37737326 P2860 Q37737326-26A1A8A2-C47F-4B7B-9EE9-D1BAF3217722 @default.
- Q37737326 P2860 Q37737326-503A7388-29FF-442C-8441-F29557393920 @default.
- Q37737326 P2860 Q37737326-509F8CA5-1A17-43D7-9D4B-33B6FC39F43A @default.
- Q37737326 P2860 Q37737326-55A84823-AF13-49E5-8AFC-D37BCEC6BB67 @default.
- Q37737326 P2860 Q37737326-587731B6-891F-4DA7-820B-AB4572D72F2E @default.
- Q37737326 P2860 Q37737326-5C5C922B-243B-4F5F-A687-89ADDE47EBD0 @default.
- Q37737326 P2860 Q37737326-6702533F-940A-4062-8F7C-B791A976AC08 @default.
- Q37737326 P2860 Q37737326-6BBC7A23-76E0-4730-8361-3E7858727CC3 @default.
- Q37737326 P2860 Q37737326-6CDC23CD-878F-40C1-B60F-8193D5174672 @default.
- Q37737326 P2860 Q37737326-7B4D15DF-ABF8-404A-8C36-263327473CA2 @default.
- Q37737326 P2860 Q37737326-7E0BDC2C-1344-4DD0-83E7-42046F973D3F @default.
- Q37737326 P2860 Q37737326-8153FDF1-5812-41E3-8B2F-F352B2BBBC9B @default.
- Q37737326 P2860 Q37737326-9B4BEA37-3930-499D-94B5-86C0BEB8D352 @default.
- Q37737326 P2860 Q37737326-B4EF5A89-25DE-49B4-B550-F82557B95DA8 @default.
- Q37737326 P2860 Q37737326-B504B93F-C51D-4DBF-AD7C-2C7D63E54069 @default.
- Q37737326 P2860 Q37737326-B7701BE3-3416-4AAC-ADD2-B71D2D8AEE8A @default.
- Q37737326 P2860 Q37737326-B7D2AF96-7B00-4A5A-B85E-03A37C3B555B @default.
- Q37737326 P2860 Q37737326-C1C89BEC-7A30-4495-BC24-6BCB13A79542 @default.
- Q37737326 P2860 Q37737326-C9634218-A57E-4258-BCDB-CC6720AC6837 @default.
- Q37737326 P2860 Q37737326-D9960C79-8F65-4C7A-A406-B29435077816 @default.
- Q37737326 P2860 Q37737326-D9CD2C2E-EF8C-47CB-9707-939DBA5752B0 @default.
- Q37737326 P2860 Q37737326-DB3B7607-F2EE-4968-A0C7-D150ED1F53E0 @default.
- Q37737326 P2860 Q37737326-F4DB19B8-7CA3-48EE-9963-3E67B746A5A4 @default.
- Q37737326 P2860 Q37737326-F564F2E3-36BC-4AF0-9000-954386D4FD90 @default.
- Q37737326 P304 Q37737326-8446D4BC-3A8B-417A-91A9-642741689019 @default.
- Q37737326 P31 Q37737326-8E46F178-53A0-4263-AA37-6871CF0700CF @default.
- Q37737326 P356 Q37737326-02AF3EB8-A802-4467-927F-D5417F143F3B @default.
- Q37737326 P407 Q37737326-0430F7DD-E67C-4A56-8567-0B16D666FFBD @default.
- Q37737326 P433 Q37737326-8101495C-A022-4502-A8C4-472FA02666DA @default.
- Q37737326 P478 Q37737326-29766F6F-B107-4194-8EFD-B31F4D6CC1B0 @default.
- Q37737326 P50 Q37737326-233F7D2D-5512-420D-8556-DB6D8B90AFFE @default.
- Q37737326 P577 Q37737326-3ECB024E-EA17-46C7-A98E-CB0F624C4518 @default.
- Q37737326 P698 Q37737326-A74C1BE0-DE55-41E6-9A6D-137F321B022B @default.
- Q37737326 P932 Q37737326-30BBCBD2-C14F-4F45-9615-7951C3A8A971 @default.
- Q37737326 P356 MD.0000000000006525 @default.
- Q37737326 P698 28353612 @default.
- Q37737326 P1433 Q15716652 @default.
- Q37737326 P1476 "The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis" @default.
- Q37737326 P2093 "Chung-Yu Chen" @default.
- Q37737326 P2093 "Kuang-Ming Liao" @default.
- Q37737326 P2093 "Yi-Hsuan Lee" @default.
- Q37737326 P2860 Q28188162 @default.
- Q37737326 P2860 Q28188182 @default.
- Q37737326 P2860 Q29615215 @default.
- Q37737326 P2860 Q33286118 @default.
- Q37737326 P2860 Q33577610 @default.
- Q37737326 P2860 Q33707148 @default.
- Q37737326 P2860 Q34019491 @default.
- Q37737326 P2860 Q34246882 @default.
- Q37737326 P2860 Q34246891 @default.
- Q37737326 P2860 Q34246898 @default.
- Q37737326 P2860 Q34384670 @default.
- Q37737326 P2860 Q34412986 @default.
- Q37737326 P2860 Q34421773 @default.
- Q37737326 P2860 Q36017142 @default.
- Q37737326 P2860 Q36287441 @default.
- Q37737326 P2860 Q36851259 @default.
- Q37737326 P2860 Q37520314 @default.
- Q37737326 P2860 Q37768524 @default.
- Q37737326 P2860 Q37847116 @default.
- Q37737326 P2860 Q38168840 @default.
- Q37737326 P2860 Q39669015 @default.
- Q37737326 P2860 Q40396157 @default.
- Q37737326 P2860 Q43771862 @default.